Search results for "MOA"

showing 10 items of 103 documents

Strength Training Improves Metabolic Health Markers in Older Individual Regardless of Training Frequency

2019

The main purpose of the present study was to investigate the effect of frequency, thereby increasing training volume, of resistance training on body composition, inflammation markers, lipid and glycemic profile in healthy older individuals (age range 65–75 year). Ninety-two healthy participants were randomly assigned to one of four groups; performing strength training one- (EX1), two- (EX2), or three- (EX3) times-per-week and a non-training control (CON) group. Whole-body strength training was performed using 2–5 sets and 4–12 repetitions per exercise and 7–9 exercises per session. All training groups attended supervised resistance training for 6 months. Body composition was measured by dua…

insulinmuscle masslcsh:QP1-981inflammationmonocyte chemoattractant protein-1blood glucoseelderlylcsh:PhysiologyFrontiers in Physiology
researchProduct

Pokolenie X i Y - podobieństwa i różnice w osobowości i hierarchii wartości między kierownikami a pracownikami na tle poczucia jakości życia

2014

kompetencjegeneracja Ygeneracja Xautonomiahierarchia wartościModel MOAGeneration X and Y - similarites and differences in personality and the hierarchy of value between managers and workers of the quality of liferelacjepoczucie jakości życia
researchProduct

Professional competences: Personality and Axiological Model (MOA) in verifying the sense of life quality

2016

Testowane w prezentowanym badaniu hipotezy zostały sformułowane w oparciu Model Osobowościowo-Aksjologiczny MOA B. Mróz, który zakłada, że poczucie jakości życia u pracowników wyższego szczebla jest uwarunkowane takimi wymiarami osobowościowo-aksjologicznymi, jak: struktura potrzeb, przystosowanie, osiągnięcia i wartości. W badaniach zastosowano: Test ACL, Wskaźnik Osiągnięć Zawodowych WOZ, Test Niedokończonych Zdań (RISB), Skalę Wartości Rokeacha oraz Kwestionariusz Poczucia Jakości Życia (KPJŻ). Za pomocą analizy regresji oraz równań strukturalnych oceniono wpływ badanych zmiennych. Okazało się, że model MOA różnicuje pracowników wyższego szczebla. Współczynnik determinacji uzyskał 47% wa…

kompetencjespecjaliścimedia_common.quotation_subjectspecialistshierarchia wartościLife qualityModel MOAjakość życiahierarchy of valuescompetencesquality of lifepłećpersonalityMOA modelgenderPersonalityosobowośćPsychologySocial psychologymedia_commonPolish Journal of Applied Psychology
researchProduct

Art of Acting and Management Style. Results of psychological research on personality and hierarchy of values of outstanding Polish actors and manager…

2018

The article – which is based on the need theory proposed by McClelland and the author’s theoretical and empirical Personality and Axiological Model – deals with the research on two groups of professionally engaged individuals: outstanding Polish actors and managers in the area of services. The results obtained indicate a significant diversity of the groups in terms of personality traits and the hierarchy of values as well as the consistency of the image in the scope of significance of dimensions related to competence and autonomy. The sphere of motivation in both groups studied is remarkably similar as well. The results show that individuals who are effective and expect professional achieve…

media_common.quotation_subjectPsychological researchmanagersManagement stylesmanagement stylehierarchy of valuesHierarchy of valuesMOApersonalityPersonalityoutstanding Polish actorsPsychologySocial psychologymedia_common
researchProduct

Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario.

2015

Abstract: Introduction: The identification of cell membrane-bound molecules with a relevant role in cancer cell survival prompted the development of moAbs to block the related pathways. In the last few years, the number of approved moAbs for cancer treatment has constantly increased. Many of these drugs significantly improved the survival outcomes in patients with solid tumours. Areas covered: In this review, all the FDA-approved moAbs in solid tumours have been described. This is an update of moAbs available for cancer treatment nowadays in comparison with the moAbs approved until few years ago. The moAbs under development are also discussed here. Expert opinion: The research on cancer ant…

medicine.medical_treatmentClinical BiochemistryCellReceptor activator of nuclear factor κB ligandCancer; Cancer antigen; Cytotoxic T-lymphocyte antigen 4; EGFR; HER2; Immunotherapy; MoAbs; Receptor activator of nuclear factor κB ligand; VEGF; Antibodies Monoclonal; Drug Approval; Drug Discovery; Humans; Immunotherapy; Neoplasms; United States; United States Food and Drug Administration; Pharmacology; Clinical Biochemistry; Drug Discovery3003 Pharmaceutical Science; Medicine (all)NeoplasmsMonoclonalDrug DiscoveryDrug approvalCancer; Cancer antigen; Cytotoxic T-lymphocyte antigen 4; EGFR; HER2; Immunotherapy; MoAbs; Receptor activator of nuclear factor κB ligand; VEGF; Antibodies; Monoclonal; Drug Approval; Drug Discovery; Humans; Immunotherapy; Neoplasms; United States; United States Food and Drug Administration; Pharmacology; Clinical Biochemistry; Drug Discovery3003 Pharmaceutical Science; Medicine (all); Cancer; Cancer antigen; Cytotoxic T-lymphocyte antigen 4; EGFR; HER2; Immunotherapy; MoAbs; Receptor activator of nuclear factor κB ligand; VEGF; Antibodies; Monoclonal; Drug Approval; Drug Discovery; Humans; Immunotherapy; Neoplasms; United States; United States Food and Drug Administration; Pharmacology; Clinical Biochemistry; Drug Discovery3003 Pharmaceutical Science; Medicine (all)Drug ApprovalCancerbiologyMedicine (all)Antibodies MonoclonalVEGFReceptor activator of nuclear factor κB ligandmedicine.anatomical_structureMonoclonalMoAbsImmunotherapyAntibodyEngineering sciences. TechnologyHumanUnited StateCancer; Cancer antigen; Cytotoxic T-lymphocyte antigen 4; EGFR; HER2; Immunotherapy; MoAbs; Receptor activator of nuclear factor κB ligand; VEGF; Antibodies Monoclonal; Drug Approval; Drug Discovery; Humans; Immunotherapy; Neoplasms; United States; United States Food and Drug Administration; Pharmacology; Clinical Biochemistry; Drug Discovery3003 Pharmaceutical Science; Medicine (all)medicine.drug_classEGFRMonoclonal antibodyAntibodiesCancer antigenCytotoxic T-lymphocyte antigen 4HER2medicineHumansBiologyPharmacologybusiness.industryUnited States Food and Drug AdministrationDrug Discovery3003 Pharmaceutical ScienceCancerImmunotherapymedicine.diseaseUnited StatesImmunologyCancer cellCancer researchbiology.proteinNeoplasmMoAbHuman medicinebusinessExpert opinion on biological therapy
researchProduct

Profiling microbial communities in hyperalkaline waters of the Kizildag ophiolite complex (Turkey).

2016

It has recently been hypothesized that life on Earth could have been originated in hyperalkaline waters related to serpentinization of ophiolitic rocks, despite their extreme conditions (high pH and very low levels of nutrients). Five hyperalkaline springs of the Kizildag ophiolite complex (Turkey) were characterized. The dominant gases are either H2, CH4 or N2 . Bacterial diversity, analysed by RISA (Ribosomal Intergenic Spacer Analysis) revealed different profles for each spring. Sequencing of excised DNA bands allowed to identify the presence of Bacillus, Ralstonia, Pseudoalteromonas., Ureibacillus, Alicycliphilus, Anaerococcus. 16S ribosomal DNA sequencing by Illumina is in progress. Th…

methanemicrobial communitieRISA pmoASettore BIO/19 - Microbiologia Generaleorigin of lifeSettore GEO/08 - Geochimica E Vulcanologia
researchProduct

The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies.

2021

Since the approval of the first monoclonal antibody (mAb) in 1986, a huge effort has been made to guarantee safety and efficacy of therapeutic mAbs. As of July 2021, 118 mAbs are approved for the European market for a broad range of clinical indications. In order to ensure clinical efficacy and safety aspects, (pre-)clinical experimental approaches evaluate the respective modes of action (MoA). In addition to antigen-specificity including binding affinity and -avidity, MoA comprise Fc-mediated effector functions such as antibody dependent cellular cytotoxicity (ADCC) and the closely related antibody dependent cellular phagocytosis (ADCP). For this reason, a variety of cell-based assays have…

modes of action (MoA)GlycosylationQH301-705.5medicine.drug_classCellReceptors FcReviewBiologyMonoclonal antibodyCatalysisInorganic Chemistrychemistry.chemical_compoundMonoklonaler Antikörper ; effector function ; antibody dependent cellular phagocytosis (ADCP) ; therapeutic monoclonal antibodies (mAbs) ; Fcγ receptor (FcγR) ; modes of action (MoA) ; antibody dependent cellular cytotoxicity (ADCC)medicineAnimalsHumansAvidityClinical efficacyBiology (General)Physical and Theoretical ChemistryReceptorQD1-999Molecular BiologySpectroscopyAntibody-dependent cell-mediated cytotoxicityEffectortherapeutic monoclonal antibodies (mAbs)Organic ChemistryAntibody-Dependent Cell CytotoxicityAntibodies Monoclonalantibody dependent cellular phagocytosis (ADCP)General MedicineFcγ receptor (FcγR)Computer Science ApplicationsImmunoglobulin Fc Fragmentsantibody dependent cellular cytotoxicity (ADCC)Chemistrymedicine.anatomical_structurechemistryImmunologyImmunotherapyeffector functionInternational journal of molecular sciences
researchProduct

Monoklonālās antivielas - mūsdienu ārstēšanas iespējas

2018

Biozāles ir viens no straujāk augošajiem farmaceitiskās rūpniecības segmentiem veselības aprūpē. Rekombinantās DNS tehnoloģijas un hibridomu tehnoloģijas progress, ir izraisījis liela mēroga proteīnu ražošanu, kuriem ir potenciāli terapeitiski pielietojumi. Kopš 1975. gada, kad pirmo reizi ziņots par monoklonālo antivielu (moAv) attīstību, pagājuši vairāk kā 40 gadi un apmēram 100 terapeitiskās moAv ir apstiprinātas kā zāles, kuras galvenokārt pielieto onkoloģisku un autoimūnu slimību terapijā. Šī pētījuma mērķis bija apzināt ārstu zināšanas par moAv un, noskaidrot ārstu pieredzi un iespējas moAv terapijas pielietošanai Latvijā. Tika veikta aptauja, kurā piedalījās 67 respondenti. Pēc aptau…

monoklonālās antivielas (moAv)audzēju terapija autoimūnas slimībasrekombinantās DNS tehnoloģijasmonoclonal antibodies (mAb)recombinant DNA technologyFarmācija
researchProduct

Neridronate prevents bone loss in patients receiving androgen deprivation therapy for prostate cancer.

2004

Today, androgen deprivation therapy is a cornerstone of treatment for advanced prostate cancer, although it presents important complications such as osteoporosis. Neridronate, a relatively new bisphosphonate, is able to prevent bone loss in patients with prostate cancer during androgen ablation. Introduction: Androgen-deprivation therapy (ADT) is a cornerstone of treatment for advanced prostate cancer. This therapy has iatrogenic complications, such as osteoporosis. The aim of our study was to evaluate the efficacy of neridronate, a relatively new bisphosphonate, to prevent bone loss during androgen ablation. Materials and Methods: Forty-eight osteoporotic patients with prostate cancer, tre…

musculoskeletal diseasesMalemedicine.medical_specialtyDeoxypyridinolineTime FactorsBicalutamideAntineoplastic Agents HormonalEndocrinology Diabetes and Metabolismmedicine.medical_treatmentOsteoporosisUrologyBone and BonesAndrogen deprivation therapychemistry.chemical_compoundProstate cancerAbsorptiometry PhotonBone DensityMedicineNeridronic acidHumansOrthopedics and Sports MedicineAmino AcidsAgedCholecalciferolTriptorelin PamoateDiphosphonatesbusiness.industryProstatic NeoplasmsAndrogen AntagonistsBisphosphonatemedicine.diseaseAlkaline PhosphataseAndrogen deprivation therapy; Bisphosphonates; Neridronate; Osteoporosis; Prostate cancer; Absorptiometry Photon; Aged; Alkaline Phosphatase; Amino Acids; Androgen Antagonists; Androgens; Antineoplastic Agents Hormonal; Bone Density; Bone and Bones; Calcium; Cholecalciferol; Diphosphonates; Humans; Male; Osteoporosis; Prostatic Neoplasms; Time Factors; Triptorelin Pamoate; SurgerySurgerychemistryAndrogensOsteoporosisCalciumbusinessCholecalciferolmedicine.drugJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
researchProduct

La genitorialità nella coppia omoaffettiva

2020

Il saggio affronta il delicato tema della aspirazione alla genitorialità procreativa da parte delle coppie omoaffettive nel nostro ordinamento alla luce dei divieti legislativi e del diritto vivente, considerati nel quadro dei principi costituzionali di riferimento. Indica argomenti e possibili soluzioni ermeneutiche per affermare un diritto alla genitorialità e per offrire adeguata copertura giuridica alla posizione del nato. The essay deals with the delicate issue of the aspiration to procreative parenthood by homosexual couples in our legal system in the light of the relevant legislative prohibitions and the recent case-law, considered within the framework of the constitutional principle…

parenthoodhomosexual couplesexual orientationgenitorialitàfamily and heterosexualityinterest of the childSettore IUS/01 - Diritto Privatocoppie omoaffettivenon-discriminationorientamento sessualenon discriminazioneinteresse del figliofamiglia ed eterosessualità
researchProduct